The Scientist

» hepatitis c

Most Recent

image: Sofosbuvir Shows Anti-Zika Activity In Vitro

Sofosbuvir Shows Anti-Zika Activity In Vitro

By | July 19, 2016

Already approved for the treatment of hepatitis C, the drug appears to impair RNA-directed RNA polymerase activity in the virus.

0 Comments

image: Compatible Company

Compatible Company

By | September 1, 2015

A guide to culturing cells with viruses in mind

0 Comments

image: Combatting Viruses with RNA-Targeted CRISPR

Combatting Viruses with RNA-Targeted CRISPR

By | April 27, 2015

Scientists reengineer a Cas9 enzyme that naturally targets bacterial RNA to stymie hepatitis C inside human cells.

0 Comments

image: Merck Snaps Up Biotech for $3.85B

Merck Snaps Up Biotech for $3.85B

By | June 10, 2014

The drug giant will acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals, which is focused on developing treatments for hepatitis C.

0 Comments

image: Study: Coffee Cuts Cancer Risk

Study: Coffee Cuts Cancer Risk

By | April 10, 2014

Evidence presented at AACR suggests that daily coffee consumption may cut a person’s risk of developing a form of liver cancer.

1 Comment

image: Viral in Valencia

Viral in Valencia

By | October 1, 2013

A genetic analysis that tracks the evolution of pathogens helped incriminate a Spanish anesthetist who infected hundreds of patients with hepatitis C.

0 Comments

image: Lab Tubes Contaminated with Virus

Lab Tubes Contaminated with Virus

By | September 20, 2013

A novel virus thought to have come from human samples appears to have been derived from seawater during the manufacture of tubes used to extract DNA.  

4 Comments

image: Phylogenetics Sheds Light on Crime

Phylogenetics Sheds Light on Crime

By | July 29, 2013

Researchers reconstructed the evolutionary histories of hepatitis C virus samples to confirm that a Spanish anesthesiologist infected 275 of his patients.

1 Comment

image: The Organist

The Organist

By | May 1, 2013

When molecular biology methods failed her, Sangeeta Bhatia turned to engineering and microfabrication to build a liver from scratch.

2 Comments

image: Canadian Scientist Declines Award

Canadian Scientist Declines Award

By | March 25, 2013

A University of Alberta researcher refuses to accept a prestigious scientific award because he thought two of his collaborators should have also been honored.

4 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham